SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-24-034178
Filing Date
2024-04-18
Accepted
2024-04-18 17:20:51
Documents
18

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0203962-s1_tffpharma.htm   iXBRL S-1 297029
2 OPINION OF GREENBERG TRAURIG, LLP ea0203962ex5-1_tffpharma.htm EX-5.1 5819
3 CONSENT OF MARCUM, LLP ea0203962ex23-1_tffpharma.htm EX-23.1 2917
4 FILING FEE TABLE ea020396201ex-fee_tffpharma.htm EX-FILING FEES 32102
5 GRAPHIC image_001.jpg GRAPHIC 7582
  Complete submission text file 0001213900-24-034178.txt   496048

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tffp-20231231.xsd EX-101.SCH 3263
7 XBRL DEFINITION FILE tffp-20231231_def.xml EX-101.DEF 5821
8 XBRL LABEL FILE tffp-20231231_lab.xml EX-101.LAB 8670
9 XBRL PRESENTATION FILE tffp-20231231_pre.xml EX-101.PRE 5651
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0203962-s1_tffpharma_htm.xml XML 1470
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-278807 | Film No.: 24855071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)